Picture of Telesis Bio logo

TBIO — Telesis Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Codex DNA Reports Q2 Loss Per Share $0.50

Aug 9 (Reuters) - Codex DNA Inc  DNAY.O :
    * CODEX DNA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.50
    * Q2 REVENUE ROSE 98 PERCENT TO $5.7 MILLION
    * CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS WERE
$61.9
MILLION AS OF JUNE 30, 2022
    * SEES FY TOTAL REVENUE IN RANGE OF $22 MILLION TO $24
MILLION, UP
FROM PRIOR GUIDANCE OF $19 MILLION TO $21 MILLION

Source text for Eikon:  ID:nGNXc4t5kT 
Further company coverage:  DNAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Telesis Bio

See all news